Literature DB >> 8986476

A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission.

P M Olaechea1, J M Quintana, M S Gallardo, J Insausti, E Maraví, B Alvarez.   

Abstract

OBJECTIVE: To create a predictive model for the treatment approach to community-acquired pneumonia (CAP) in patients needing Intensive Care Unit (ICU) admission.
DESIGN: Multicenter prospective study.
SETTING: Twenty-six Spanish ICUs. PATIENTS: One hundred seven patients with CAP, all of them with accurate etiological diagnosis, divided in three groups according to their etiology in typical (bacterial pneumonia), Legionella and other atypical (Mycoplasma, Chlamydia spp. and virus). For the multivariate analysis we grouped Legionella and other atypical etiologies in the same category.
METHODS: We recorded 34 variables including clinical characteristics, risk factors and radiographic pattern. We used a multivariate logistic regression analysis to find out a predictive model.
RESULTS: We have the complete data in 70 patients. Four variables: APACHE II, (categorized as a dummy variable) serum sodium and phosphorus and "length of symptoms" gave an accurate predictive model (c = 0.856). From the model we created a score that predicts typical pneumonia with a sensitivity of 90.2% and specificity 72.4%.
CONCLUSION: Our model is an attempt to help in the treatment approach to CAP in ICU patients based on a predictive model of basic clinical and laboratory information. Further studies, including larger numbers of patients, should validate and investigate the utility of this model in different clinical settings.

Entities:  

Mesh:

Year:  1996        PMID: 8986476     DOI: 10.1007/bf01709541

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  32 in total

1.  The outcome of community acquired pneumonia treated on the intensive care unit.

Authors:  M Alkhayer; P F Jenkins; B D Harrison
Journal:  Respir Med       Date:  1990-01       Impact factor: 3.415

2.  Hyponatraemia in Legionnaires' disease.

Authors:  A C Miller
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

3.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee.

Authors:  B M Farr; D L Kaiser; B D Harrison; C K Connolly
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

Review 4.  The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias.

Authors:  B A Cunha
Journal:  Med Clin North Am       Date:  1995-05       Impact factor: 5.456

5.  Community-acquired pneumonia: impact of immune status.

Authors:  L M Mundy; P G Auwaerter; D Oldach; M L Warner; A Burton; E Vance; C A Gaydos; J M Joseph; R Gopalan; R D Moore
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

6.  Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias.

Authors:  M A Woodhead; J T Macfarlane
Journal:  Br J Dis Chest       Date:  1987-04

7.  Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.

Authors:  A Ortqvist; G Sterner; J A Nilsson
Journal:  Scand J Infect Dis       Date:  1985

8.  Early clinical differentiation between Legionnaires' disease and other sporadic pneumonias.

Authors:  A C Miller
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

9.  Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias.

Authors:  C M Helms; J P Viner; R H Sturm; E D Renner; W Johnson
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

10.  A three-year study of severe community-acquired pneumonia with emphasis on outcome.

Authors:  J Rello; E Quintana; V Ausina; A Net; G Prats
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

View more
  9 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.

Authors:  L A Mandell; T J Marrie; R F Grossman; A W Chow; R H Hyland
Journal:  Can J Infect Dis       Date:  2000-09

Review 4.  Severe community-acquired pneumonia: what do we need to know to effectively manage patients?

Authors:  M S Niederman
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

5.  Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia.

Authors:  Sigismond Lasocki; Agnès Scanvic; Françoise Le Turdu; Aymeric Restoux; Hervé Mentec; Gérard Bleichner; Jean-Pierre Sollet
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

6.  [Update to the Latin American Thoracic Association (ALAT) recommendations on community acquired pneumonia].

Authors: 
Journal:  Arch Bronconeumol       Date:  2004-08       Impact factor: 4.872

7.  Typical or atypical pneumonia and severe acute respiratory symptoms in PICU.

Authors:  Kam Lun Hon; Agnes S Y Leung; Kam Lau Cheung; Antony C Fu; Winnie Chiu Wing Chu; Margaret Ip; Paul K S Chan
Journal:  Clin Respir J       Date:  2014-06-09       Impact factor: 2.570

Review 8.  Paediatrics: how to manage septic shock.

Authors:  Kam Lun Hon; Karen Ka Yan Leung; Felix Oberender; Alexander Kc Leung
Journal:  Drugs Context       Date:  2021-06-01

9.  Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.

Authors:  Andrew P Walden; Geraldine M Clarke; Stuart McKechnie; Paula Hutton; Anthony C Gordon; Jordi Rello; Jean-Daniel Chiche; Frank Stueber; Christopher S Garrard; Charles J Hinds
Journal:  Crit Care       Date:  2014-04-01       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.